drug · antibody
nimacimab
Phase 2updated 3mo agoby $SKYE Skye Bioscience, Inc.🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 2 (across all indications), with 3 investigational indications.
indications
indications
Obesity
targets
Cannabinoid receptor 1
all catalysts(0)
nothing on the calendar yet
Trials studying nimacimab
News(1)
- Skye and Redx form new entity with $125M to advance fibrosis assetsSkye Bioscience has entered into an agreement to combine with privately held fibrotic disease biotech Redx Pharma in a deal that will net $125 million in financing for the new public company, calle…fiercebiotech · 6d ago
Data sources
last refreshed 27m ago
Found something off?
comments(0)
5-min edit window · permanent after that